All filters
Abstracts
Burdensome health-related issues affecting people living with HIV in Spain in the context of high antiretroviral coverage: a qualitative study
J. Lazarus
Presented at:
Workshop on Healthy Living with HIV 2020
Abstracts
Impact of HIV on Treatment and Outcome after Acute Myocardial Infarction: A Swedish Nationwide Observational Cohort Study
G. Marrone
Presented at:
Workshop on Healthy Living with HIV 2020
Abstracts
HIV care for women living with HIV in Brighton: a description of a one-stop, integrated model of care: the Sunflower Clinic
G. Villa
Presented at:
Workshop on Healthy Living with HIV 2020
Abstracts
E-health for HIV service delivery in the context of the COVID-19 Pandemic
S. Emmanuel
Presented at:
Workshop on Healthy Living with HIV 2020
Abstracts
Women above 50 navigating life with new HIV diagnosis in rural South Africa: a phenomenological study.
B.Mathabela
Presented at:
Workshop on Healthy Living with HIV 2020
Abstracts
Perceived barriers on accessing reproductive health services among adolescent and youth living with physical disability in Ehlanzeni district, Mpumalanga Province, South Africa.
B. Mathabela
Presented at:
Workshop on Healthy Living with HIV 2020
Abstracts
Twenty-four week safety, tolerability and efficacy of dolutegravir dispersible tablets in children 4 weeks to <6 years old with HIV: results from IMPAACT P1093
T. Ruel
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysis
R. Singh
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Safety, pharmacokinetics, and efficacy of low-dose E/C/F/TAF in virologically suppressed children ≥2 years old living with HIV
E. Natukunda
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Safety, pharmacokinetics and acceptability of the ABC/3YC/LPV/R granules (4-in-1) in children living with HIV (3-20kg) in Uganda: LOLIPOP study
J. Mwanga-Amumpaire
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver-child dyads’ perspective
A. Rotsaert
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
The “DTGs” of DTG for children and adolescents living with HIV (CALHIV): Descriptions, Trends, and Gaps of rolling out dolutegravir in CALHIV in Mbeya, Tanzania.
J. Bacha
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
A validated outpatient department HIV screening tool for children 18 months to 14 years as efficient as index testing in Uganda
K. Ashburn
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Point of Care SAMBA-II vs Centralized Laboratory Viral Load Assays among HIV-1 Infected Children, Adolescents and Young Adults in Rural Zimbabwe: A Randomized Controlled Trial
V. Kouamou
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
“Right under our nose”: A simple screening tool to identify HIV-positive children outside of the PMTCT program at outpatient departments in Malawi
A. Tallmadge
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Finding the remaining unidentified children living with HIV: Opportunities through index testing
A. Amzel, M. Gleason
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Development and Validation of the HIV Adolescent Readiness for Transition Scale (HARTS)
B. Zanoni
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Factors associated with late presentation of HIV-infected infants for Early Infant HIV Diagnosis (EID) services in Kenya
A. Langat
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Antiretroviral Drug Transition and Adverse Event Monitoring among Adolescents 15 to 19 years of age in Kenya
M. Syowai
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Point-of-Care Viral Load Testing Among Adolescents and Young Adults Living with HIV in Haiti: A Randomized Control Trial
L. Reif
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Bringing HIV and SRH services closer to Adolescents Girls and Young Women in Eswatini through a comprehensive mobile HIV and SRH package
S. Wusumani
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Archived HIV-1 Drug-Resistance Variants in Cellular Reservoirs and its Determinants among Vertically-Infected Adolescents failing Antiretroviral Therapy
J. Fokam
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Deficits noted at 11 years in children with HIV starting early antiretroviral therapy in fine motor dexterity and auditory working memory
B. Laughton
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Challenges of remdesivir pediatric development for SARS-CoV-2 infection in a pandemic
C. Pikora
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020